Not applicableLooking for participantsNCT05776212What this trial is testingQuantitative-imaging in Cardiac Transthyretin AmyloidosisWho this might be right forATTR-CM University of Edinburgh 140
Not applicableStudy completedNCT04801329What this trial is testingKorean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid CardiomyopathyWho this might be right forATTR-CM (Transthyretin Amyloid Cardiomyopathy) Pfizer 110
Large-scale testing (Phase 3)Active Not RecruitingNCT06194825What this trial is testingEPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid CardiomyopathyWho this might be right forTransthyretin Amyloid Cardiomyopathy AstraZeneca 64
Post-approval studies (Phase 4)Looking for participantsNCT07695701What this trial is testingCardiac Magnetic Resonance and Echocardiography Study With AcoramidisWho this might be right forTransthyretin Amyloidosis Cardiomyopathy (ATTR-CM)AmyloidosisAmyloid Cardiomyopathy+1 more Eidos Therapeutics, a BridgeBio company 150
Not applicableUnknownNCT04985734What this trial is testingTransthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Patients With Idiopathic Peripheral NeuropathyWho this might be right forAmyloidosis CardiacAmyloid PolyneuropathyAmyloidosis+3 more University Hospital, Antwerp 200
Not applicableUnknownNCT05210010What this trial is testingA Prospective Study to Assess the Utility of CA-4F in a Canadian Cardiology SettingWho this might be right forTransthyretin Amyloid Cardiomyopathy ("ATTR-CM") Ensho Health Intelligent Systems Inc. 8
Early research (Phase 1)Ended earlyNCT03417830What this trial is testingBiodistribution of 89Zirconium-labelled GSK2398852 Using PET ImagingWho this might be right forAmyloidosis GlaxoSmithKline 2
Not applicableStudy completedNCT04108091What this trial is testingVyndaqel Capsules Special Investigation (ATTR-CM)Who this might be right forTransthyretin (TTR) Amyloid Cardiomyopathy Pfizer 1,214
Not applicableEnrolling By InvitationNCT07238426What this trial is testingATTRACT-52: Primary Care Cardiac Amyloidosis Screening in Ordu, TurkeyWho this might be right forCardiac AmyloidosisTransthyretin Amyloidosis Kotyora Family Medicine Health Management and Education Association 800
Large-scale testing (Phase 3)Looking for participantsNCT06128629What this trial is testingMAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)Who this might be right forTransthyretin Amyloidosis (ATTR) With Cardiomyopathy Intellia Therapeutics 1,200
Not applicableLooking for participantsNCT07112066What this trial is testingMultimodality Cardiac Imaging for Disease Progression in ATTR-CMWho this might be right forAmyloidosis Cardiac Dominik Benz 50
Not applicableLooking for participantsNCT06465810What this trial is testingNon-interventional Study of Patients With Transthyretin (ATTR) AmyloidosisWho this might be right forTransthyretin AmyloidosisATTR-CMATTRv-PN+3 more AstraZeneca 1,850
Not applicableStudy completedNCT06393465What this trial is testingReal-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid CardiomyopathyWho this might be right forTransthyretin Amyloidosis Cardiomyopathy (ATTR-CM) Pfizer 50
Testing effectiveness (Phase 2)Looking for participantsNCT06318260What this trial is testingHaemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)Who this might be right forATTR Amyloidosis Wild Type Steen Hvitfeldt Poulsen 15
Not applicableActive Not RecruitingNCT07062848What this trial is testingAn Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.Who this might be right forTransthyretin (TTR) Amyloid Cardiomyopathy Yale University 1,500,000
Large-scale testing (Phase 3)Study completedNCT01994889What this trial is testingSafety and Efficacy of Tafamidis in Patients With Transthyretin CardiomyopathyWho this might be right forTransthyretin (TTR) Amyloid Cardiomyopathy Pfizer 441
Not applicableActive Not RecruitingNCT07338942What this trial is testingImplementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk PopulationsWho this might be right forATTR-CM AstraZeneca 4,000
Not applicableLooking for participantsNCT07791160What this trial is testingStudy of Acoramidis in Patients With Transthyretin Amyloid CardiomyopathyWho this might be right forTransthyretin Amyloid Cardiomyopathy (ATTR-CM) Bayer 500
Large-scale testing (Phase 3)Looking for participantsNCT07207811What this trial is testingCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) AmyloidosisWho this might be right forTransthyretin Amyloid Cardiomyopathy (ATTR CM) Novo Nordisk A/S 1,280
Not applicableNot Yet RecruitingNCT07557147What this trial is testingSingle-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-MonitorWho this might be right forTransthyretin Amyloid Cardiomyopathy (ATTR-CM) Bayer 60